Ocugen to Present at BIO International Convention 2024
29 mai 2024 07h15 HE
|
Ocugen
MALVERN, Pa., May 29, 2024 (GLOBE NEWSWIRE) -- Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a biotechnology company focused on discovering, developing, and commercializing novel gene and...
Ocugen Set to Join Russell 3000® Index Effective June 28, 2024
28 mai 2024 07h02 HE
|
Ocugen
MALVERN, Pa., May 28, 2024 (GLOBE NEWSWIRE) -- Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a biotechnology company focused on discovering, developing, and commercializing novel gene and...
Global Tonometer Market Forecast Report 2024-2029, with Profiles of Haag-Streit, HEMC Medical, Reichert Technologies, Diaton, Jaggi Brothers, Advin Healthcare, Keeler, Takagi Japan, Inami & Nidek-Intl
27 mai 2024 07h32 HE
|
Research and Markets
Dublin, May 27, 2024 (GLOBE NEWSWIRE) -- The "Tonometer Market - Forecasts from 2024 to 2029" report has been added to ResearchAndMarkets.com's offering. The tonometry industry is experiencing...
Global Juvenile Macular Degeneration Clinical Trials Review 2024, Featuring Lin Bioscience, Nanoscope Therapeutics, Alnylam Pharmaceuticals, Biophytis, Kubota Pharmaceutical and Nucleus Network
27 mai 2024 05h00 HE
|
Research and Markets
Dublin, May 27, 2024 (GLOBE NEWSWIRE) -- The "Juvenile Macular Degeneration (Stargardt Disease) - Global Clinical Trials Review, 2024" clinical trials has been added to ResearchAndMarkets.com's...
Global Wet (Neovascular / Exudative) Macular Degeneration Clinical Trials Review 2024
27 mai 2024 02h49 HE
|
Research and Markets
Dublin, May 27, 2024 (GLOBE NEWSWIRE) -- The "Wet (Neovascular / Exudative) Macular Degeneration - Global Clinical Trials Review, 2024" clinical trials has been added to ResearchAndMarkets.com's...
Global Nonmydriatic Handheld Fundus Cameras Strategic Research Report 2024: Market to Reach $259 Million by 2030 - Glaucoma Prevalence and Need for Screening to Fuel Sales
23 mai 2024 11h08 HE
|
Research and Markets
Dublin, May 23, 2024 (GLOBE NEWSWIRE) -- The "Nonmydriatic Handheld Fundus Cameras - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.Global Nonmydriatic...
Clearside Biomedical Announces Publication of Consensus Guidelines for Drug Delivery via Suprachoroidal Space (SCS®) Injection in Leading Peer-Reviewed Industry Journal, RETINA®
21 mai 2024 07h05 HE
|
Clearside Biomedical, Inc.
- Expert Panel of Ophthalmologists Developed Professional Guidelines in Using the Innovative Technique for Retinal Therapeutic Delivery - - Current Clinical Evidence and Physician Experience Support...
Ocugen Announces CSO to Present on Modifier Gene Therapy at International Society for Cell & Gene Therapy 2024
20 mai 2024 07h00 HE
|
Ocugen
MALVERN, Pa., May 20, 2024 (GLOBE NEWSWIRE) -- Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a biotechnology company focused on discovering, developing, and commercializing novel gene and...
Ocugen Announces Dosing Completion of Subjects with Stargardt Disease in Cohort 2 of Phase 1/2 GARDian Clinical Trial of OCU410ST—A Modifier Gene Therapy
15 mai 2024 06h30 HE
|
Ocugen
MALVERN, Pa., May 15, 2024 (GLOBE NEWSWIRE) -- Ocugen, Inc. (“Ocugen” or the “Company”) (NASDAQ: OCGN), a biotechnology company focused on discovering, developing, and commercializing novel gene and...
Ocugen to Present at May 2024 Investor Conferences
10 mai 2024 07h45 HE
|
Ocugen
MALVERN, Pa., May 10, 2024 (GLOBE NEWSWIRE) -- Ocugen, Inc. (“Ocugen” or the “Company”) (NASDAQ: OCGN), a biotechnology company focused on discovering, developing, and commercializing novel gene and...